The unified social credit code/registration number of Sino-American Tianjin SmithKline Pharmaceutical Co., Ltd. is 911060055017xm, and Yao Peichun is an enterprise legal person. At present, the enterprise is in the state of opening.
The business scope of Sino-American Tianjin SmithKline Pharmaceutical Co., Ltd. is: production, processing, packaging and sales of cream, nasal plaster, tablets, hard capsules, ointments, imported drugs (small volume injections), health care products and related products; Engaged in the wholesale, retail, import and export of oral care products and chemical products and other related supporting businesses, and provided after-sales service; Wholesale, retail and import and export of cosmetics, disinfection products, prepackaged foods and bulk food (the above commodities subject to quota license management and special provisions shall be handled in accordance with relevant state regulations); Dealing in medical devices and drugs (the above contents shall be subject to the Medical Device Business License and Drug Business License) (the import and export of the above commodities does not involve state-owned trade, and import and export quota licenses, export quota tenders, export licenses and other commodities with special provisions shall be handled in accordance with relevant state regulations); Technology promotion service, marketing service and medical consultation service. (If the above business scope involves industry license, it shall be operated within the validity period with the license; If the state has special provisions on franchising, it shall be handled according to the provisions. )。 In Tianjin, the total registered capital of companies with similar business scope is 1 004,7 1 000 yuan, and the main capital is concentrated in 225 enterprises with a scale of over 50 million,1000- 1 000 million. In the province, the registered capital of enterprises is excellent.
Sino-American Tianjin SmithKline Pharmaceutical Co., Ltd. invested in 0 companies and 3 branches.
See more information and materials of Sino-American Tianjin SmithKline Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.